Literature DB >> 18803309

Survival and disability in a cohort of neural tube defect births in Dublin, Ireland.

Marie Sutton1, Leslie E Daly, Peadar N Kirke.   

Abstract

BACKGROUND: Neural tube defects (NTDs) are a major cause of death and disability. Periconceptional folic acid prevents up to 70% of these malformations but public health campaigns to increase use of supplements have had disappointing results: The proposed mandatory fortification of bread products in Ireland has raised concerns about possible side effects. We examined data collected on a cohort of children born with NTDs in an era before fortification/supplementation to illustrate the serious consequences in terms of survival and disability.
METHODS: All 623 infants born with NTDs in the Dublin area between 1976 and 1987 were included. Information was collected on mortality and length of survival for those who died, and for those who survived at least 5 years, interview-based data were collected on age, place of residence, prevalence of hydrocephalus, degree of disability, schooling, and IQ.
RESULTS: Seventy-four births (12%) were stillborn. Of the livebirths only 41% were alive at 5 years. Factors associated with mortality were type of lesion, level of lesion, presence of other defects, hydrocephalus, year of birth, and gestation. Of the children who survived to 5 years or more, 75% had a disability and 56% were severely disabled. Type of lesion and level of lesion influenced disability risk. Of the survivors, 51% of children had mobility limitations, 59% were incontinent, 42% had hydrocephalus, and 17% had intellectual disability.
CONCLUSIONS: These findings illustrate the devastating consequences of NTDs and underline the importance of effective intervention programs with folic acid for prevention. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18803309     DOI: 10.1002/bdra.20498

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  8 in total

1.  Neural Tube Defects and Associated Factors among Neonates Admitted to the Neonatal Intensive Care Units in Hiwot Fana Specialized University Hospital, Harar, Ethiopia.

Authors:  Yunus Edris; Hanan Abdurahman; Assefa Desalew; Fitsum Weldegebreal
Journal:  Glob Pediatr Health       Date:  2020-11-13

2.  Neonatal and infant mortality associated with spina bifida: A systematic review and meta-analysis.

Authors:  Peter Ho; Maria A Quigley; Dharamveer Tatwavedi; Carl Britto; Jennifer J Kurinczuk
Journal:  PLoS One       Date:  2021-05-12       Impact factor: 3.240

Review 3.  Folic acid food fortification-its history, effect, concerns, and future directions.

Authors:  Krista S Crider; Lynn B Bailey; Robert J Berry
Journal:  Nutrients       Date:  2011-03-15       Impact factor: 5.717

4.  Analysis of Mortality among Neonates and Children with Spina Bifida: An International Registry-Based Study, 2001-2012.

Authors:  Marian K Bakker; Vijaya Kancherla; Mark A Canfield; Eva Bermejo-Sanchez; Janet D Cragan; Saeed Dastgiri; Hermien E K De Walle; Marcia L Feldkamp; Boris Groisman; Miriam Gatt; Paula Hurtado-Villa; Karin Kallen; Daniella Landau; Nathalie Lelong; Jorge S Lopez Camelo; Laura Martínez; Margery Morgan; Osvaldo M Mutchinick; Wendy N Nembhard; Anna Pierini; Anke Rissmann; Antonin Sipek; Elena Szabova; Giovanna Tagliabue; Wladimir Wertelecki; Ignacio Zarante; Pierpaolo Mastroiacovo
Journal:  Paediatr Perinat Epidemiol       Date:  2019-10-21       Impact factor: 3.980

5.  Folate-related gene variants in Irish families affected by neural tube defects.

Authors:  Ridgely Fisk Green; Julianne Byrne; Krista S Crider; Margaret Gallagher; Deborah Koontz; Robert J Berry
Journal:  Front Genet       Date:  2013-11-06       Impact factor: 4.599

6.  Prevention of congenital malformations and other adverse pregnancy outcomes with 4.0 mg of folic acid: community-based randomized clinical trial in Italy and the Netherlands.

Authors:  Renata Bortolus; Fenneke Blom; Francesca Filippini; Mireille N M van Poppel; Emanuele Leoncini; Denhard J de Smit; Pier Paolo Benetollo; Martina C Cornel; Hermien E K de Walle; Pierpaolo Mastroiacovo
Journal:  BMC Pregnancy Childbirth       Date:  2014-05-13       Impact factor: 3.007

7.  Prenatal folic acid use associated with decreased risk of myelomeningocele: A case-control study offers further support for folic acid fortification in Bangladesh.

Authors:  Vijaya Kancherla; Md Omar Sharif Ibne Hasan; Rezina Hamid; Ligi Paul; Jacob Selhub; Godfrey Oakley; Quazi Quamruzzaman; Maitreyi Mazumdar
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

Review 8.  Intelligence Quotient in Patients with Myelomeningocele: A Review.

Authors:  Yusuf Alimi; Joe Iwanaga; Rod J Oskouian; Marios Loukas; R Shane Tubbs
Journal:  Cureus       Date:  2018-08-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.